Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

BACKGROUND: Osteoprotegerin (OPG) is a tumour and/or bone derived factor that may protect tumour cells from apoptosis. In this study, we have measured serum OPG levels in untreated prostate cancer patients with advanced prostate cancer compared to patients with organ confined disease and in treated...

書誌詳細
主要な著者:	Eaton, C, Wells, J, Holen, I, Croucher, P, Hamdy, F
フォーマット:	Journal article
言語:	English
出版事項:	2004

類似資料

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
著者:: Eaton, C, 等
出版事項: (2004)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
著者:: Holen, I, 等
出版事項: (2002)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
著者:: Holen, I, 等
出版事項: (2002)

Role of osteoprotegerin (OPG) in cancer.
著者:: Holen, I, 等
出版事項: (2006)

The role of osteoprotegerin in breast and prostate cancer
著者:: Holen, I, 等
出版事項: (2002)

OPG is a survival factor for breast- and prostate cancer cells in vitro
著者:: Holen, I, 等
出版事項: (2002)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
著者:: Miles, L, 等
出版事項: (2004)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
著者:: Gamal B Mohamed, 等
出版事項: (2011-01-01)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
著者:: Holen Ingunn, 等
出版事項: (2009-07-01)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
著者:: Lili Zhang, 等
出版事項: (2016-11-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
著者:: Riham Eid, 等
出版事項: (2023-06-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
著者:: Indra Wijaya, 等
出版事項: (2024-01-01)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
著者:: Croucher, P, 等
出版事項: (2000)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
著者:: Saba Tariq, 等
出版事項: (2022-02-01)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
著者:: Shipman, C, 等
出版事項: (2002)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
著者:: Siamak Kazemi-Sufi, 等
出版事項: (2024-09-01)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
著者:: Shipman, C, 等
出版事項: (2000)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
著者:: Shipman, C, 等
出版事項: (2002)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
著者:: Noura N. Alraouji, 等
出版事項: (2024-08-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
著者:: Chan Kai-Ming, 等
出版事項: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
著者:: Syed Muhammad Muneeb Akhtar, 等
出版事項: (2024-07-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
著者:: Waterman, E, 等
出版事項: (2007)

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
著者:: Alice Wang, 等
出版事項: (2021-07-01)

Analysis of periodontal parameteres and salivary levels of Receptor Activator of NF- κβ Ligand (RANKL) and Osteoprotegerin (OPG) in obese periodontitis patients
著者:: Cheema, Raheem Ramzan
出版事項: (2021)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
著者:: Yao Jing, 等
出版事項: (2011-03-01)

Changes of serum osteoprotegerin level in recurrent urolithiasis
著者:: A. V. Savilov, 等
出版事項: (2023-10-01)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
著者:: Hamdy, F
出版事項: (2005)

Osteoprotegerin and the development of myeloma bone disease
著者:: Croucher, P, 等
出版事項: (2004)

Dickkopf-1 levels and serum Osteoprotegerin in women with Osteoporosis
著者:: Mehrzad Hajialilo, 等
出版事項: (2013-12-01)

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
著者:: Veselina Goranova-Marinova, 等
出版事項: (2007-07-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
著者:: Martin Widschwendter, 等
出版事項: (2015-10-01)

Enhancing androgen ablation response in metastatic hormone-sensitive prostate cancer: the benefits of transurethral resection of the prostate
著者:: Yan Zhao, 等
出版事項: (2023-07-01)

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression
著者:: Jong-Kwang Kim, 等
出版事項: (2021-12-01)

The influence of vitamin D administration on the clinical presentation, body mass index, and osteoprotegerin (OPG) level in a sample of Egyptian children with familial Mediterranean fever
著者:: Hanaa Reyad Abdallah, 等
出版事項: (2021-12-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
著者:: F. F. Rija, 等
出版事項: (2021-10-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
著者:: Yen-Liang Chen, 等
出版事項: (2023-10-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
著者:: Yosra Azizpour, 等
出版事項: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
著者:: Yosra Azizpour, 等
出版事項: (2020-01-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
著者:: Croucher, P, 等
出版事項: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
著者:: Croucher, P, 等
出版事項: (2001)